Access cutting-edge lung cancer treatment through this clinical trial at a research site in Yuma. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Yuma at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
This study is researching an investigational drug called fianlimab (also called REGN3767) with two other medications called cemiplimab and chemotherapy, individually called a "study drug" or collectively called "study drugs". 'Investigational' means that the study drug is not approved for use outside of this study by any Health Authority. Examples of chemotherapy drugs include the following: Paclitaxel plus carboplatin, and Pemetrexed plus cisplatin. The study is being conducted in patients who
Sponsor: Regeneron Pharmaceuticals
Check if you qualify for this lung cancer clinical trial in Yuma, AZ
If you're searching for lung cancer treatment options in Yuma, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Yuma research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.